Thomas J. Musci

Thomas J. Musci, MD served from 2012 to 2016 as Chief Medical Officer at Ariosa Diagnostics, which was acquired by Roche Diagnostics. Dr. Musci held past positions in the maternal-fetal medicine program at the California Pacific Medical Center in San Francisco, as Associate Clinical Professor at the University of California School of Medicine, and as Director of Clinical Affairs, Predictive Health at Novartis Diagnostics, Inc. Dr. Musci served as the past chair of the Committee on Genetics for the American Congress of Obstetricians and Gynecologists (ACOG), and as a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics (ACMG). Dr. Musci is on the editorial advisory board of the American Journal of Obstetrics and Gynecology and is an ad hoc peer reviewer of several professional publications. In addition, he has authored and co-authored many publications on topics including cell-free DNA technology, preeclampsia, fibroblast growth factor, FISH, gene expression, and prenatal screening.

Dr. Musci graduated from Georgetown University School of Medicine and continued his medical training at the University of California by completing an internship and a residency in obstetrics and gynecology; fellowships in maternal-fetal medicine, cardiovascular research, and medical genetics; and postdoctoral research with Marc Kirschner, PhD, in the department of biochemistry and biophysics. He is board certified in obstetrics and gynecology, maternal-fetal medicine, and medical genetics.